摘要
目的探讨血清前白蛋白检测在抗结核治疗患者肝损伤中的意义。方法选择60例进行抗结核治疗患者为观察组,同期健康体检者30例为对照组。分别检测观察组治疗前后3个月血清前白蛋白、ALT,并与健康体检者检测结果比较。结果观察组患者在肺结核治疗前与健康体检者血清前白蛋白、ALT检测结果差异无统计学意义(P>0.05)。观察组治疗后3个月,血清前白蛋白显著低于对照组,差异有统计学意义(P<0.05)。观察组治疗后3个月ALT水平显著高于对照组,差异有统计学意义(P<0.05)。结论血清PA水平为判断抗结核治疗早期肝功能损伤的重要指标,可作为抗结核治疗后肝功能检测的常规指标推广。
Objective To study the clinical value of the detection of serum prealbumin in anti-tu- patients with liver damage. Methods 60 patients were treated with anti-tuberculosis as group, at the same time 30 cases of physical examination as control group. Observa- was detected before and after treatment for 3 months＇ serum prealbumin and ALT, forcomparing with the healthy physical examination results. Results There was no statistically sig- nificant difference in observation group of patients with serum preaIbumin, ALT test results before tuberculosis treatment（P〉0.05）. After 3 months＇ treatment in observation group, serum albumin was significantly lower than the control group, the difference was statistically significant （P〈0.05）.The ALT level was icant （P〈0.05）. significantly higher than that of control group.The difference was statistically signif- Conclusion Serum PA level as judging the important indicator of treating liver function damage in early anti-tuberculosis, can be used as index to promote regular anti-tb treat- ment after liver function tests.
出处
《现代诊断与治疗》
CAS
2013年第11期2407-2409,共3页
Modern Diagnosis and Treatment
关键词
前白蛋白
ALT
抗结核治疗
肝损伤
Prealbumin
ALT
Anti-tuberculosis treatment
Liver damage
